We often hear about the benefits artificial intelligence (AI) can bring to medicine and healthcare through drug research, but could it also pose a threat?

Researchers from Collaborations Pharmaceuticals, a North Carolina-based drug discovery company, have published a paper that highlights the dangerous potential of AI and machine learning to discover biochemical weapons.

By simply tweaking a machine learning model called MegaSyn to reward instead of penalise predicted...